Paper41001338
Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children.
Qin M and 3 others. Front Pharmacol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children. Papers, record 41001338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacovigilance practice on off-label high-dose of vancomycin in severely ill children.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32242356 | Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32242356 | PubMed |
| 2 | 12741439 | Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity. | Pharmacotherapy | 2003 | https://conductscience.org/library/papers/12741439 | PubMed |
| 3 | 34750740 | Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review. | Eur J Drug Metab Pharmacokinet | 2022 | https://conductscience.org/library/papers/34750740 | PubMed |
| 4 | 33839974 | Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years. | AAPS J | 2021 | https://conductscience.org/library/papers/33839974 | PubMed |
| 5 | 22411630 | Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. | Eur J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22411630 | PubMed |
| 6 | 30833429 | Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30833429 | PubMed |
| 7 | 27585904 | Clinical Pharmacology Studies in Critically Ill Children. | Pharm Res | 2017 | https://conductscience.org/library/papers/27585904 | PubMed |
| 8 | 32191793 | Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. | Am J Health Syst Pharm | 2020 | https://conductscience.org/library/papers/32191793 | PubMed |
| 9 | 30216124 | Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30216124 | PubMed |
| 10 | 33161460 | Baseline kidney function is associated with vancomycin-induced acute kidney injury in children: a prospective nested case-control study. | Pediatr Nephrol | 2021 | https://conductscience.org/library/papers/33161460 | PubMed |
| 11 | 31935538 | Correlation of the vancomycin 24-h area under the concentration-time curve (AUC24) and trough serum concentration in children with severe infection: A clinical pharmacokinetic study. | Int J Infect Dis | 2020 | https://conductscience.org/library/papers/31935538 | PubMed |
| 12 | 31378957 | Vancomycin is commonly under-dosed in critically ill children and neonates. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31378957 | PubMed |
| 13 | 24515100 | Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/24515100 | PubMed |
| 14 | 34233034 | Children may need higher vancomycin doses to achieve therapeutic levels. | Acta Paediatr | 2021 | https://conductscience.org/library/papers/34233034 | PubMed |
| 15 | 24315788 | Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia. | Int J Antimicrob Agents | 2014 | https://conductscience.org/library/papers/24315788 | PubMed |
| 16 | 28973124 | Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children. | JAMA Pediatr | 2017 | https://conductscience.org/library/papers/28973124 | PubMed |
| 17 | 31301023 | Clinical Pharmacokinetics of Vancomycin in Critically Ill Children. | Eur J Drug Metab Pharmacokinet | 2019 | https://conductscience.org/library/papers/31301023 | PubMed |
| 18 | 21208910 | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21208910 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41001338
GET https://conductscience.org/api/papers/v1/41001338/authors